Farha MA, Brown ED. Drug repurposing for antimicrobial discovery. Nat Microbiol. 2019;4:565–7.
Article CAS PubMed Google Scholar
Boucher HW, Talbot GH, Bradley JS. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1–12.
Manandhar S, Luitel S, Dahal RK. In vitro antimicrobial activity of some medicinal plants against human pathogenic bacteria. J Trop Med. 2019;2019:1–5.
Trigo-Gutierrez JK, Vega-Chacón Y, Soares AB, Mima EGDO. Antimicrobial activity of curcumin in nanoformulations: a comprehensive review. Int J Mol Sci. 2021;22:7130–78.
Article CAS PubMed PubMed Central Google Scholar
Eftekhari-Sis B, Zirak M, Akbari A. Arylglyoxals in Synthesis of Heterocyclic Compounds. Chem Rev. 2013;113:2958–3043.
Article CAS PubMed Google Scholar
Ansari A, Ali A, Asif M. Biologically active pyrazole derivatives. N. J Chem. 2017;41:16–41.
Ju Y, Varma RS. Aqueous N-Heterocyclization of Primary Amines and Hydrazines with Dihalides: Microwave-Assisted Syntheses of N-Azacycloalkanes, Isoindole, Pyrazole, Pyrazolidine, and Phthalazine Derivatives. J Org Chem. 2006;71:135–41.
Article CAS PubMed Google Scholar
Zárate-Zárate D, Aguilar R, Hernández-Benitez RI, Labarrios EM, Delgado F, Tamariz J. Synthesis of α-ketols by functionalization of captodative alkenes and divergent preparation of heterocycles and natural products. Tetrahedron. 2015;71:6961–78.
Faisal M, Saeed A, Hussain S, Dar P, Larik FA. Recent developments in synthetic chemistry and biological activities of pyrazole derivatives. J Chem Sci. 2019;131:1–30.
Karrouchi K, Radi S, Ramli Y, Taoufik J, Mabkhot YN, Al-Aizari FA, et al. Synthesis and pharmacological activities of pyrazole derivatives: A review. Molecules. 2018;23:134–219.
Article PubMed Central Google Scholar
Mor S, Khatri M, Punia R, Sindhu S. Recent Progress in Anticancer Agents Incorporating Pyrazole Scaffold. Mini-Rev Med Chem. 2022;22:115–63.
Article CAS PubMed Google Scholar
Mor S, Khatri M, Punia R, Nagoria S, Sindhu S. A new insight into the synthesis and biological activities of pyrazole based derivatives. Mini-Rev Org Chem. 2022;19:717–78.
Bakr FAW, Kamal MD. Synthesis and applications of bipyrazole systems. ARKIVOC. 2012;491:491–545.
Ahsan MJ, Samy JG, Soni S, Jain N, Kumar L, Sharma LK, et al. Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues. Bioorg Med Chem Lett. 2011;21:5259–61.
Article CAS PubMed Google Scholar
Ahsan MJ, Samy JG, Khalilullah H, Bakht MA, Hassan MZ. Synthesis and antimycobacterial evaluation of 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues. Eur J Med Chem. 2011;46:5694–7.
Article CAS PubMed Google Scholar
Lemke TL, Cramer MB, Shanmugam K. Heterocyclic tricycles as potential CNS agents I: 4-aminoalkylindeno[1,2-c]pyrazoles. J Pharma Sci. 1978;67:1377–81.
Loev B, Mosher WA. Pyrazoloindenone azines. 1961; U.S. Patent No. 2,969,374.
Angelone T, Caruso A, Rochais C, Caputo AM, Cerra MC, Dallemagne P, et al. Indenopyrazole Oxime Ethers: Synthesis and ß1-Adrenergic Blocking Activity. Eur J Med Chem. 2015;92:672–81.
Article CAS PubMed Google Scholar
Murineddu G, Lazzari P, Ruiu S, Sanna A, Loriga G, Manca I, et al. Tricyclic Pyrazoles. 4. Synthesis and Biological Evaluation of Analogues of the Robust and Selective CB2 Cannabinoid Ligand 1-(2ˈ,4ˈ-Dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide. J Med Chem. 2006;49:7502–12.
Article CAS PubMed Google Scholar
Ahsan MJ, Govindasamy J, Khalilullah H, Mohan G, Stables JP, Pannecouque C, et al. POMA analyses as new efficient bioinformatics’ platform to predict and optimise bioactivity of synthesized 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues. Bioorg Med Chem Lett. 2012;22:7029–35.
Article CAS PubMed Google Scholar
Hamilton RW. The antiarrhythmic and antiinflammatory activity of a series of tricyclic pyrazoles. J Heterocycl Chem. 1976;13:545–53.
Shareef MA, Sirisha K, Khan I, Sayeed IB, Jadav SS, Ramu G, et al. synthesis, and antimicrobial evaluation of 1,4-dihydroindeno[1,2-c]pyrazole tethered carbohydrazide hybrids: exploring their in silico ADMET, ergosterol inhibition and ROS inducing potential. Med Chem Comm. 2019;10:806–13.
Mor S, Khatri M. Synthesis, antimicrobial evaluation, α-amylase inhibitory ability and molecular docking studies of 3-alkyl-1-(4-(aryl/heteroaryl)thiazol-2-yl)indeno[1,2-c]pyrazol-4(1H)-ones. J Mol Struct. 2022;1249:131526–35.
Minegishi H, Futamura Y, Fukashiro S, Muroi M, Kawatani M, Osada H, et al. Methyl 3-((6-methoxy-1,4-dihydroindeno [1,2-c]pyrazol-3-yl) amino)benzoate (GN39482) as a tubulin polymerization inhibitor identified by MorphoBase and ChemProteoBase profiling methods. J Med Chem. 2015;58:4230–41.
Article CAS PubMed Google Scholar
Shahlaei M, Fassihi A, Saghaie L, Arkan E, Madadkar-Sobhani A, Pourhossein A. Computational evaluation of some indenopyrazole derivatives as anticancer compounds; application of QSAR and docking methodologies. J Enz Inhib Med Chem. 2013;28:16–32.
Liu YN, Wang JJ, Ji YT, Zhao GD, Tang LQ, Zhang CM, et al. Design, synthesis, and biological evaluation of 1-methyl-1, 4-dihydroindeno[1,2-c]pyrazole analogues as potential anticancer agents targeting tubulin colchicine binding site. J Med Chem. 2016;59:5341–55.
Article CAS PubMed Google Scholar
Khan I, Shareef MA, Kumar GC. An overview on the synthetic and medicinal perspectives of indenopyrazoles. Eur J Med Chem. 2019;178:1–12.
Article CAS PubMed Google Scholar
Pathak N, Rathi E, Kumar N, Kini SG, Rao CM. A review on anticancer potentials of benzothiazole derivatives. Mini-Rev Med Chem. 2020;20:12–23.
Article CAS PubMed Google Scholar
Tariq S, Kamboj P, Amir M. Therapeutic advancement of benzothiazole derivatives in the last decennial period. Arch der Pharmazie. 2019;352:1800170–86.
Keri RS, Patil MR, Patil SA, Budagumpi SA. Comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry. Eur J Med Chem. 2015;89:207–51.
Article CAS PubMed Google Scholar
Gunawardana GP, Kohmoto S, Gunasekera SP, McConnell OJ, Koehn FE. Dercitine, a new biologically active acridine alkaloid from a deep water marine sponge, Dercitus sp. J Am Chem Soc. 1988;110:4856–8.
Mor S, Sindhu S. Synthesis, Type II diabetes inhibitory activity, antimicrobial evaluation and docking studies of indeno[1,2-c]pyrazol-4(1H)-ones. Med Chem Res. 2020;29:46–62.
Article CAS PubMed Google Scholar
Kilgore LB, Ford JH, Wolfe WC. Insecticidal properties of 1,3-indandiones. Ind Eng Chem. 1942;34:494–7.
Dhawan SN, Mor S, Sharma K, Chawla AD, Saini A, Gupta SC. On the mechanism of formation of pyrazoles from 1,3-diketones and hydrazines: isolation of hydroxypyrazoline intermediates. Indian J Chem Sect B. 1994;33:38–42.
Gupta SC, Quarishi MA, Dhawan SN. Synthesis of 6-phenyl-7H-indeno[2,1-c]quinoline and 2-methyl-6-phenyl-7H-indeno[2,1-c]quinoline. Indian J Chem Sect B. 1979;18:547–8.
Hugerschoff H. Effect of bromine on aromatic thioureas. Chem Ber. 1903;36:3121–34.
Mor S, Mohil R, Nagoria S, Kumar A, Lal K, Kumar D, et al. Regioselective synthesis, antimicrobial evaluation and QSAR studies of some 3‐aryl‐1‐heteroarylindeno[1,2‐c]pyrazol‐4(1H)‐ones. J Heterocycl Chem. 2017;54:1327–41.
Mor S, Nagoria S. Efficient and convenient synthesis, characterization, and antimicrobial evaluation of some new tetracyclic 1,4-benzothiazines. Synth Commun. 2016;46:169–78.
留言 (0)